Target Market
Total Addressable Market (TAM)
– 530 million adults globally at risk of diabetes
Serviceable Addressable Market (SAM)
– 96 million adults in the U.S. with prediabetes
Serviceable Obtainable Market (SOM)
– Targeting 0.5% of the U.S. market initially
– Approximately 480,000 individuals
Competitor Overview
Direct Competitors:
– No direct competitors currently targeting prediabetes monitoring.
Indirect Competitors:
Dexcom & Abbott:
– Focus on glucose monitoring for type 2 diabetes patients.
– Invasive methods requiring blood samples.
Traditional Diagnostic Labs:
– Fasting, blood draws, and clinic visits required.
Financial Picture
We aim to raise $75,000 over the next 12 months through a diversified funding strategy. This includes grants, owner contributions, and investor funding to support R&D, prototyping, and commercialization milestones
